TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -84.2% | 167 | -86.3% | 0.00% | – |
| Q2 2023 | $19 | +533.3% | 1,217 | +628.7% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 167 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 167 | -89.7% | 0.00% | – |
| Q3 2022 | $21,000 | +950.0% | 1,628 | +874.9% | 0.00% | – |
| Q2 2022 | $2,000 | -95.9% | 167 | -95.1% | 0.00% | – |
| Q1 2022 | $49,000 | -9.3% | 3,390 | -14.6% | 0.00% | – |
| Q4 2021 | $54,000 | -11.5% | 3,971 | +6.1% | 0.00% | – |
| Q3 2021 | $61,000 | -7.6% | 3,744 | -5.0% | 0.00% | – |
| Q2 2021 | $66,000 | +6.5% | 3,940 | +16.2% | 0.00% | – |
| Q1 2021 | $62,000 | +785.7% | 3,390 | +811.3% | 0.00% | – |
| Q3 2020 | $7,000 | +600.0% | 372 | +389.5% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 76 | +68.9% | 0.00% | – |
| Q2 2019 | $1,000 | -87.5% | 45 | -88.7% | 0.00% | – |
| Q1 2019 | $8,000 | – | 397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |